Haleon plc
HLN
Rank in Stocks
#13784
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
Share Price
$5.01
Market Cap
$440.22M
Change (1 day)
-2.22%
Change (1 year)
8.34%
Country
GB
Trade Haleon plc (HLN)
Category
Healthcare
Stock price history for Haleon plc (HLN)
Highest end of day price: $4.68 on 2026-10-01
Lowest end of day price: $3.48 on 2022-07-01
Lowest end of day price: $3.48 on 2022-07-01
Stock price history of Haleon plc from 2022 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -0.77% |
| 2025 | 2.79% |
| 2024 | 16.19% |
| 2023 | 13.23% |
| 2022 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 21.02% |
DE
|
|
| $41.46 | 47.41% |
JP
|
|
| $212.49 | 23.19% |
CH
|
|
| $19.19 | -0.09% |
IN
|
